Statins in diabetics, beyond cholesterol……?

Author： Voshol Peter J Havekes Louis M Romijn Johannes A

ISSN： 1746-0875

Source： Future Lipidology, Vol.1, Iss.6, 2006-12, pp. : 667-671

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beyond cholesterol reduction, the pleiotropic effects of statins: is their use in cancer prevention hype or hope?

By Barkas Fotis Rizzo Manfredi DiNicolantonio James J Liberopoulos Evangelos

Clinical Lipidology, Vol. 8, Iss. 3, 2013-06 ,pp. : 273-277

Future Medicine

Access to resources Recommend Favorite

Pleiotropic Effects of Statins and Beyond

Cardiology, Vol. 112, Iss. 1, 2008-06 ,pp. : 1-3

Karger

Access to resources Recommend Favorite

Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study

MOVEMENT DISORDERS, Vol. 30, Iss. 4, 2015-04 ,pp. : 552-559

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is the Use of Cholesterol-Lowering Drugs for the Prevention of Cardiovascular Complications in Type 2 Diabetics Evidence-Based? A Systematic Review

Reviews on Recent Clinical Trials, Vol. 7, Iss. 2, 2012-05 ,pp. : 150-157

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular pathology of familial hypercholesterolemia, related dyslipidemias and therapies beyond the statins

By Faiz Fathimath Hooper Amanda J. van Bockxmeer Frank M.

Critical Reviews in Clinical Laboratory Sciences, Vol. 49, Iss. 1, 2012-02 ,pp. : 1-17

Informa Healthcare

Access to resources Recommend Favorite